Your institution may have access to this item. Find your institution then sign in to continue.
Title
Highlights in Hepatitis B Virus Treatment From the 2016 Annual Meeting of the American Association for the Study of Liver Diseases.
Abstract
The article discusses studies on hepatitis B virus (HBV) treatment highlighted during the 2016 Annual Meeting of the American Association for the Study of Liver Diseases held in Boston, Massachusetts from November 11 to 15, 2016. Topics discussed include the use of tenofovir alafenamide in treating chronic HBV, HBV treatment effectiveness of drugs tenofovir disoproxil fumarate and pegylated interferon, and GS-9620 as a treatment option for HBV patients suppressed by anti-viral treatment.